Business Wire

Masimo Announces CE Marking of Radius Capnography™ for the Root ® Patient Monitoring and Connectivity Platform

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that Radius Capnography™, a portable real-time capnograph with wireless Bluetooth ® connectivity, has received CE marking ...
Business Wire

New Study Investigates Impact of General Ward Clinical Monitoring Using Masimo Root ®, Radius-7 ®, and Patient SafetyNet™ on Clinical Workflow and Patient Care

LEBANON, N.H.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Dartmouth-Hitchcock Medical Center investigated the impact of ...
Nasdaq

Masimo Announces FDA Clearance of Radius PCG™ for the Root® Patient Monitoring and Connectivity Platform

IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that Radius PCG™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received FDA 510(k) clearance.
Yahoo UK & Ireland

Masimo's Radius 7 Wearable Monitor Gets FDA 510 (k) Nod

Masimo Corporation MASI recently announced the receipt of FDA 510 (k) approval for the Radius 7 wearable, tetherless, non-invasive rainbow monitor device. This follows the recent approval of the O3 ...